Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rink

Showing results (191-200 of 292) with videos related to

Pageof 30
Sort By:
Urologic Oncology|November 24, 2019
8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survivalTill Eichenauer, David C Bannenberg, Martina Kluth, et al.
Minerva Urology and Nephrology|June 11, 2021
Impact of the preoperative modified Glasgow Prognostic Score on disease outcome after radical cystectomy for urothelial carcinoma of the bladderVictor M Schuettfort, Kilian Gust, David D'Andrea, et al.
Frontiers in Oncology|July 18, 2022
A Systematic Review and Meta-Analysis of Prognostic Nomograms After UTUC SurgeryMaximilian Pallauf, Frederik König, David D'Andrea, et al.
BJU International|March 2, 2021
A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinomaVictor M Schuettfort, David D'Andrea, Fahad Quhal, et al.
BJU International|March 8, 2013
Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomyEvanguelos Xylinas, Michael Rink, Vitaly Margulis, et al.
Urologic Oncology|January 18, 2014
Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladderLily C Wang, Evanguelos Xylinas, Matthew T Kent, et al.
World Journal of Urology|October 27, 2014
Multi-institutional validation of the prognostic value of Ki-67 labeling index in patients treated with radical prostatectomyRomain Mathieu, Shahrokh F Shariat, Christian Seitz, et al.
European Urology Focus|March 13, 2022
Reassessment of the Efficacy of Carboplatin for Metastatic Urothelial Carcinoma in the Era of Immunotherapy: A Systematic Review and Meta-analysisKeiichiro Mori, Victor M Schuettfort, Takafumi Yanagisawa, et al.
World Journal of Urology|May 23, 2016
Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomyMihai Dorin Vartolomei, Romain Mathieu, Vitaly Margulis, et al.
BJU International|September 24, 2013
Prognosis of patients with pelvic lymph node (LN) metastasis after radical prostatectomy: value of extranodal extension and size of the largest LN metastasisNiccolo M Passoni, Harun Fajkovic, Evanguelos Xylinas, et al.
Pageof 30

Showing results (191-200 of 292) with videos related to

Sort By:
Pageof 30
Urologic Oncology|November 24, 2019
8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survivalTill Eichenauer, David C Bannenberg, Martina Kluth, et al.
Minerva Urology and Nephrology|June 11, 2021
Impact of the preoperative modified Glasgow Prognostic Score on disease outcome after radical cystectomy for urothelial carcinoma of the bladderVictor M Schuettfort, Kilian Gust, David D'Andrea, et al.
Frontiers in Oncology|July 18, 2022
A Systematic Review and Meta-Analysis of Prognostic Nomograms After UTUC SurgeryMaximilian Pallauf, Frederik König, David D'Andrea, et al.
BJU International|March 2, 2021
A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinomaVictor M Schuettfort, David D'Andrea, Fahad Quhal, et al.
BJU International|March 8, 2013
Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomyEvanguelos Xylinas, Michael Rink, Vitaly Margulis, et al.
Urologic Oncology|January 18, 2014
Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladderLily C Wang, Evanguelos Xylinas, Matthew T Kent, et al.
World Journal of Urology|October 27, 2014
Multi-institutional validation of the prognostic value of Ki-67 labeling index in patients treated with radical prostatectomyRomain Mathieu, Shahrokh F Shariat, Christian Seitz, et al.
European Urology Focus|March 13, 2022
Reassessment of the Efficacy of Carboplatin for Metastatic Urothelial Carcinoma in the Era of Immunotherapy: A Systematic Review and Meta-analysisKeiichiro Mori, Victor M Schuettfort, Takafumi Yanagisawa, et al.
World Journal of Urology|May 23, 2016
Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomyMihai Dorin Vartolomei, Romain Mathieu, Vitaly Margulis, et al.
BJU International|September 24, 2013
Prognosis of patients with pelvic lymph node (LN) metastasis after radical prostatectomy: value of extranodal extension and size of the largest LN metastasisNiccolo M Passoni, Harun Fajkovic, Evanguelos Xylinas, et al.
Pageof 30